1. Platelet surface expression of stromal cell–derived factor‐1 receptors CXCR4 and CXCR7 is associated with clinical outcomes in patients with coronary artery disease. (13th March 2015) Authors: Rath, D.; Chatterjee, M.; Borst, O.; Müller, K.; Langer, H.; Mack, A. F.; Schwab, M.; Winter, S.; Gawaz, M.; Geisler, T. Journal: Journal of thrombosis and haemostasis Issue: Volume 13:Number 5(2015:May) Page Start: 719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0406 Iv cyclophosphamide vs. rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomised, controlled trial. (12th June 2018) Authors: Sircar, G.; Goswami, R.P.; Sircar, D.; Rath, D.; Mondal, S.; Mahapatra, P.S.; Ghosh, A.; Ghosh, P. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Triplex-hybridizing bioconjugated gold nanoparticles for specific Y-chromosome sequence targeting of bull spermatozoa. Issue 11 (10th May 2017) Authors: Gamrad, L.; Mancini, R.; Werner, D.; Tiedemann, D.; Taylor, U.; Ziefuß, A.; Rehbock, C.; Klein, S.; Kues, W.; Barcikowski, S.; Rath, D. Journal: Analyst Issue: Volume 142:Issue 11(2017) Page Start: 2020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗